AD patients are reported to have an increased abundance of Blautia, which is correlated with more severe AD pathology, namely, lower levels of Aβ42/Aβ40 and higher levels of p-tau and p-tau/Aβ42 in the cerebrospinal fluid [22]. This evidence concerns the gene MAPT and Alzheimer disease.